106
Participants
Start Date
August 31, 2011
Primary Completion Date
July 31, 2013
Study Completion Date
October 31, 2013
KHK4563
every 4 weeks for the first 3 doses on Weeks 0 (Day 1), 4, and 8 and then every 8 weeks thereafter for the last 4 doses on Weeks 16, 24, 32, and 40.
KHK4563
every 4 weeks for the first 3 doses on Weeks 0 (Day 1), 4, and 8 and then every 8 weeks thereafter for the last 4 doses on Weeks 16, 24, 32, and 40.
KHK4563
every 4 weeks for the first 3 doses on Weeks 0 (Day 1), 4, and 8 and then every 8 weeks thereafter for the last 4 doses on Weeks 16, 24, 32, and 40.
Placebo
every 4 weeks for the first 3 doses on Weeks 0 (Day 1), 4, and 8 and then every 8 weeks thereafter for the last 4 doses on Weeks 16, 24, 32, and 40.
Nagoya
Toyota-shi
Kamogawa-shi
Fukuoka
Ogaki-shi
Hiroshima
Sapporo
Himeji-shi
Kobe
Sagamihara-shi
Yokohama
Kumamoto
Kyoto
Nagasaki
Kishiwada-shi
Koshigaya-shi
Shizuoka
Itabashi-ku
Shinagawa-ku
Shinjuku-ku
Mizunami-shi
Osakasayama-shi
Oura-gun
Seto-shi
Chungcheongbuk-do
Gwangju
Gyenggi-do
Seoul
Suwon
Kyowa Kirin Co., Ltd.
INDUSTRY